Beleodaq (Spectrum Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Beleodaq drug offered from Spectrum Pharmaceuticals, Inc.. This Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Spectrum Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Belinostat
SUBSTANCE NAME: BELINOSTAT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-07-21
END MARKETING DATE: 0000-00-00


Beleodaq HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBeleodaq from Spectrum Pharmaceuticals, Inc.
LABELER NAME: Spectrum Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/10mL)
START MARKETING DATE: 2014-07-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68152-108_0b349468-289d-4267-bc4e-456ae16896e0
PRODUCT NDC: 68152-108
APPLICATION NUMBER: NDA206256

Other BELINOSTAT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Spectrum Pharmaceuticals, Inc.Beleodaq